BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/28/2025 6:46:31 AM | Browse: 7 | Download: 0
Category |
Health Care Sciences & Services |
Manuscript Type |
Clinical Trials Study |
Article Title |
Efficacy of Xiaokeqing granules and lifestyle intervention in treating prediabetes mellitus considering metabolomic biomarkers: A randomised controlled trial
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jin-Dong Zhao, Meng-Zhu Guo, Yi Zhang, Shao-Hua Zhu, Ya-Ting Wang, Yan-Ping Zhang, Xin Liu, Si Cheng, Fei Wang, Qi Xu, Nuo-Bing Ruan and Zhao-Hui Fang |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Open Bidding for Selecting the Best Candidates for Xin’an Medicine and the Modernization of Traditional Chinese Medicine of IHM |
No. 2023CXMMTCM024 |
Open Bidding for Selecting the Best Candidates for Xin’an Medicine and the Modernization of Traditional Chinese Medicine of IHM |
No. 2023CXMMTCM003 |
Anhui University Collaborative Innovation Project |
No. GXXT-2020-025 |
Scientific Research Project of Health and Wellness in Anhui Province |
No. AHWJ2023BAc10002 |
Anhui Province New Era Education Quality Project |
No. 2023 gjxslt014 |
Clinical and Translational Research Project of Anhui Province |
No. 202427b10020046 |
|
Corresponding Author |
Zhao-Hui Fang, Department of Endocrinology, The First Affiliated Hospital of Anhui University of Chinese Medicine, No. 117 Meishan Road, Hefei 230031, Anhui Province, China. fangzhaohui1111@163.com |
Key Words |
Prediabetes mellitus; Xiaokeqing granules; Lifestyle; Two-hour postprandial glucose; Metabolomics; Tryptophan metabolism |
Core Tip |
In this study, Xiaokeqing granules constitute a new class-three traditional Chinese medicine. They can improve 2-hour postprandial glucose in participants with prediabetes mellitus with yin deficiency syndrome with excessive heat according to a preliminary investigation and an exploratory randomised controlled trial. Groenlandicine and kaempferol are the main Xiaokeqing granule constituents absorbed into the blood. N-Nervonoyl methionine and 5-hydroxy-L-tryptophan are potential biomarkers for the effectiveness of Xiaokeqing granules and lifestyle interventions. |
Citation |
Zhao JD, Guo MZ, Zhang Y, Zhu SH, Wang YT, Zhang YP, Liu X, Cheng S, Wang F, Xu Q, Ruan NB, Fang ZH. Efficacy of Xiaokeqing granules and lifestyle intervention in treating prediabetes mellitus considering metabolomic biomarkers: A randomised controlled trial. World J Diabetes 2025; In press |
 |
Received |
|
2025-01-15 12:14 |
 |
Peer-Review Started |
|
2025-01-17 01:06 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-03-21 06:51 |
 |
Revised |
|
2025-04-02 16:51 |
 |
Second Decision |
|
2025-05-23 00:45 |
 |
Accepted by Journal Editor-in-Chief |
|
2025-05-27 14:51 |
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-28 06:46 |
 |
Articles in Press |
|
2025-05-28 06:46 |
 |
Publication Fee Transferred |
|
2025-04-03 14:29 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345